Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K, Tanabe Y, Kubota D, Akaike K, Hayashi T, Mogushi K, Hosoya M, Sato S, Kobayashi E, Okubo T, Kim Y, Kohsaka S, Saito T, Kaneko K, Suehara Y.
Mukaihara K, et al. Among authors: kubota d.
PLoS One. 2017 Sep 25;12(9):e0185321. doi: 10.1371/journal.pone.0185321. eCollection 2017.
PLoS One. 2017.
PMID: 28945796
Free PMC article.